Ji Lin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Advanced Cancer

Network Analysis

Top Venues

Statistics in medicine

Statistics in biopharmaceutical research

Clinical cancer research : an official journal of the American Association for Cancer Research

Emory University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Emory University Sep 01 2005 - Jan 29 2012

United States

PHD :: Biostatistics and Bioinformatics

Publications

Yuhan Li, Yiding Zhang, Gu Mi, Ji Lin
A seamless phase II/III design with dose optimization for oncology drug development. Statistics in medicine 43 (18) (2024)
Yuhan Li, Yiding Zhang, Gu Mi, Ji Lin
A seamless phase II/III design with dose optimization for oncology drug development. Statistics in medicine (2024)
Ray S Lin, Ji Lin, Satrajit Roychoudhury, Keaven M Anderson, Tianle Hu, Bo Huang, Larry F Leon, Jason J Z Liao, Rong Liu, Xiaodong Luo, Pralay Mukhopadhyay, Rui Qin, Kay Tatsuoka, Xuejing Wang, Yang Wang, Jian Zhu, Tai-Tsang Chen, Renee Iacona, null null
Rejoinder to Letter to the Editor "The Hazards of Period Specific and Weighted Hazard Ratios". Statistics in biopharmaceutical research 12 (4) (2020)
Johanna C Bendell, Anna M Varghese, David M Hyman, Todd M Bauer, Shubham Pant, Sophie Callies, Ji Lin, Ricardo Martinez, Enaksha Wickremsinhe, Aaron Fink, Volker Wacheck, Kathleen N Moore
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (14) (2018)